Supplemental information (Tables)

9 Months Ended

May 31, 2019

Balance Sheet Related Disclosures [Abstract]

Schedule of Depreciation and Amortization Expense

The Company has recorded the following depreciation and amortization expense in the Consolidated Condensed Statements of Earnings (in millions):

	Three months ended May 31,				Nine months ended May 31,
	2019		2018		2019		2018
Depreciation expense	$	379	$	358	$	1,096	$	1,040
Intangible asset and other amortization	142		84		415		260
Total depreciation and amortization expense	$	522	$	442	$	1,512	$	1,300

Schedule of Cash and Cash Equivalents

The following represents a reconciliation of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash, cash equivalents and restricted cash in the Consolidated Condensed Statements of Cash Flows as of May 31, 2019 and August 31, 2018 (in millions):

	May 31, 2019		August 31, 2018
Cash and cash equivalents	$	839	$	785
Restricted cash (included in other current assets)	199		190
Cash, cash equivalents and restricted cash	$	1,038	$	975

Restrictions on Cash and Cash Equivalents

The following represents a reconciliation of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash, cash equivalents and restricted cash in the Consolidated Condensed Statements of Cash Flows as of May 31, 2019 and August 31, 2018 (in millions):

	May 31, 2019		August 31, 2018
Cash and cash equivalents	$	839	$	785
Restricted cash (included in other current assets)	199		190
Cash, cash equivalents and restricted cash	$	1,038	$	975

Schedule of Dividends Payable

Cash dividends per common share declared during the nine months ended fiscal 2019 and the nine months ended fiscal 2018 were as follows:

Quarter ended	2019		2018
November	$	0.440	$	0.400
February	0.440		0.400
May	0.440		0.400
	$	1.320	$	1.200